Is a complete PASG research report available?

No complete published report is available for Passage Bio, Inc. (PASG) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Passage Bio, Inc. (PASG)

NASDAQ: PASG · USD

$4.49

-0.03 (-0.7%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first PASG analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	14.4M
Net income (ttm)	-37.7M
EPS (ttm)	-$11.8
Shares out	3.2M
Volume	5,216
Beta	1.42
Price target	$15.5	+245.2%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -37.7M
EPS (ttm): -$11.8
Market cap: 14.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All PASG indicators

Market & fundamental data

Available fields

184

Groups with data

Currency

USD

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001787297
Company name	Passage Bio, Inc.
Country	United States
Country code	US
Cusip	702712209
Employees	24
Employees Change	-36%
Employees Change Percent	-60
Enterprise value	$-13.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-02-28
Isin	US7027122099
Last refreshed	2026-07-31
Market cap	$14.4M
Market cap category	Nano-Cap
Price	$4.49
Price currency	USD
Sector	Healthcare
Sector PE	45.56
Sector PE Fwd	24.38
Sic	2836
Symbol	PASG
Website	https://www.passagebio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-261.58%
FCF yield	-212.79%
P/B ratio	1.23x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-37.7M
Net Income Growth Quarters	1%
Net Income Growth Years	4%
Profit Per Employee	$-1.6M
ROA	-39
Roa5y	-31.43
ROCE	-251.2
ROE	-128.9
Roe5y	-73.19
ROIC	-53.47

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-29.2%
Cagr3y	-36.51%
Cagr5y	-55.1%
EPS Growth Quarters	1
EPS Growth Years	4
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$36.5M
Cash	$33.3M
Current Assets	$34.7M
Current Liabilities	$20.1M
Debt	$5.8M
Debt Equity	$0.49
Equity	$11.8M
Liabilities	$24.7M
Long Term Assets	$1.7M
Long Term Liabilities	$4.6M
Net Cash	$27.6M
Net Cash By Market Cap	$191
Net Cash Growth	-27.88%
Net Debt Equity	$-2.35
Tangible Book Value	$11.8M
Tangible Book Value Per Share	$3.66
WACC	8.62

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.73
Net Working Capital	$-17.6M
Quick ratio	1.66
Working Capital	$14.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.55%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-29.18%
200-day SMA	8.03
3Y total return	-74.41%
50-day SMA	5.16
50-day SMA vs 200-day SMA	50under200
5Y total return	-98.17%
All Time High	764.6
All Time High Change	-99.41%
All Time High Date	2020-06-24
All Time Low	3.29
All Time Low Change	36.47%
All Time Low Date	2026-06-25
ATR	0.35
Beta	1.42
Beta1y	3.87
Beta2y	2.15
Ch YTD	-61.95
High	4.67
High52	20
High52 Date	2026-01-09
High52ch	-77.55%
Low	4.48
Low52	3.29
Low52 Date	2026-06-25
Low52ch	36.47%
Ma50ch	-12.92%
Price vs 200-day SMA	-44.07%
RSI	39.73
RSI Monthly	35.79
RSI Weekly	41.24
Sharpe ratio	0.27x
Sortino ratio	0.44
Total Return	-0.55%
Tr YTD	-61.95
Tr1m	-7.42%
Tr1w	-8.37%
Tr3m	-16.07%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	3
Analyst Price Target Top	$23
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-2.71
Operating Income	$-38.2M
Price target	$15.5
Price Target Change	$245
Price Target Change Top	$412

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,886,814%
Float Percent	89.99%
Shares Insiders	0.5%
Shares Institutions	54.03%
Shares Out	3,207,810
Shares Qo Q	0.82%
Shares Yo Y	0.55%
Short Float	4.32%
Short Ratio	0.83
Short Shares	3.89

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-33.3M
Adjusted OCF	-33,348,000
Average Volume	42,193.25x
Bv Per Share	3.66
Ch1m	-7.42
Ch1w	-8.37
Ch1y	-29.18
Ch3m	-16.07
Ch3y	-74.41
Ch5y	-98.17
Ch6m	-58.15
Change	-0.66%
Change From Open	0.34
Close	4.52
Days Gap	-1
Depreciation Amortization	656,000
Dollar Volume	23,419.8
Earnings Date	2026-08-07
Earnings Time	bmo
EBIT	$-41.1M
EBITDA	$-40.4M
EPS	$-11.84
F Score	1
FCF	$-30.6M
FCF EV Yield	232.58x
FCF Per Share	$-9.55
Financing CF	23,000
Fiscal Year End	December
Founded	2,017
Investing CF	605,000
Ipr	-75.06
Iprfo	-98.99
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-12
Last Report Date	2026-03-31
Last Split Date	2025-07-14
Last Split Type	Reverse
Last10k Filing Date	2026-03-03
Ma150	7.89
Ma150ch	-43.11%
Ma20	4.74
Ma20ch	-5.17%
Net CF	-30,021,000
Next Earnings Date	2026-08-11
Open	4.48
Optionable	No
Position In Range	7.69
Post Close	4.49
Postmarket Change Percent	1.34
Postmarket Price	$4.55
Ppne	1,477,000
Price Date	2026-07-30
Ptbv Ratio	1.23
Relative Volume	0.12x
Share Based Comp	2,699,000
Tr6m	-58.15%
Us State	Pennsylvania
Volume	5,216

Passage Bio, Inc. (PASG)

Coverage state: Market snapshot only — no published research

Generate the first PASG analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · PASG

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PASG indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on PASG

Frequently asked questions